Glenmede Trust CO Na Gilead Sciences, Inc. Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

A detailed history of Glenmede Trust CO Na transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 292,048 shares of GILD stock, worth $26.3 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

292,048

Previous 326,759 10.62%

Holding current value

$26.3 Million

Previous $22.4 Million 9.19%

% of portfolio

0.12%

Previous 0.11%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $2.31 Million - $2.92 Million	-34,711 Reduced 10.62%	292,048 $24.5 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $2.11 Million - $2.44 Million	-33,427 Reduced 9.28%	326,759 $22.4 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $936,982 - $1.14 Million	-13,090 Reduced 3.51%	360,186 $26.4 Million
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $607,847 - $689,314	8,296 Added 2.27%	373,276 $30.2 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $2.93 Million - $3.2 Million	39,619 Added 12.18%	364,980 $27.4 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $18,470 - $21,068	-243 Reduced 0.07%	325,361 $25.1 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $4.28 Million - $4.87 Million	55,315 Added 20.47%	325,604 $27 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $6.46 Million - $9.28 Million	103,696 Added 62.25%	270,289 $23.2 Million
Q3 2022 Nov 16, 2022	BUY	$59.54 - $68.01 $65,374 - $74,674	1,098 Added 0.66%	166,593 $10.3 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $2.36 Million - $2.66 Million	-40,886 Reduced 19.81%	165,495 $10.2 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $591,652 - $741,404	10,215 Added 5.21%	206,381 $12.3 Million
Q4 2021 Feb 15, 2022	SELL	$64.88 - $73.64 $727,888 - $826,167	-11,219 Reduced 5.41%	196,166 $14.2 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $1.05 Million - $1.14 Million	-15,551 Reduced 6.98%	207,385 $14.5 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $2.86 Million - $3.13 Million	-45,066 Reduced 16.82%	222,936 $15.4 Million
Q1 2021 May 18, 2021	SELL	$60.0 - $68.46 $16.1 Million - $18.4 Million	-268,308 Reduced 50.03%	268,002 $17.3 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $8.33 Million - $9.49 Million	-146,992 Reduced 21.51%	536,310 $31.2 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $9.74 Million - $12.2 Million	-156,876 Reduced 18.67%	683,302 $43.2 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $6.03 Million - $7.01 Million	83,410 Added 11.02%	840,178 $64.6 Million
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $4.05 Million - $4.46 Million	-65,777 Reduced 8.0%	756,768 $49.2 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $22.6 Million - $25 Million	-362,065 Reduced 30.56%	822,545 $52.1 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $28 Million - $31.3 Million	451,770 Added 61.65%	1,184,610 $80 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $26.6 Million - $29.7 Million	-424,686 Reduced 36.69%	732,840 $47.6 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $8.98 Million - $11.7 Million	148,334 Added 14.7%	1,157,526 $72.4 Million
Q3 2018 Nov 15, 2018	BUY	$71.28 - $78.92 $23.5 Million - $26 Million	329,998 Added 48.59%	1,009,192 $77.9 Million
Q2 2018 Aug 15, 2018	BUY	$64.88 - $75.68 $2.07 Million - $2.42 Million	31,937 Added 4.93%	679,194 $48.1 Million
Q4 2017 Feb 15, 2018	BUY	$71.15 - $83.52 $1.69 Million - $1.98 Million	23,751 Added 3.81%	647,257 $46.4 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $45 Million - $53.3 Million	623,506	623,506 $0

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Gilead Sciences, Inc. Transaction History